CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation

被引:57
作者
Abou-Rjaily, GA
Lee, SJ
May, D
Al-Share, QY
DeAngelis, AM
Ruch, RJ
Neumaier, M
Kalthoff, H
Lin, SH
Najjar, SM
机构
[1] Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA
[2] Ivonex GmbH, Kiel, Germany
[3] Med Coll Ohio, Dept Pathol, Toledo, OH 43614 USA
[4] Univ Clin Mannheim, Inst Clin Chem, Mannheim, Germany
[5] Univ Hosp Schleswig Holstein, Clin Gen & Thorac Surg, Kiel, Germany
[6] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA
关键词
D O I
10.1172/JCI200421786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Phosphorylation of the cell adhesion protein CEACAM1 increases insulin sensitivity and decreases insulin-dependent mitogenesis in vivo. Here we show that CEACAM1 is a substrate of the EGFR and that upon being phosphorylated, CEACAM1 reduces EGFR-mediated growth of transfected Cos-7 and MCF-7 cells in response to EGF. Using transgenic mice overexpressing a phosphorylation-defective CEACAM1 mutant in liver (L-SACC1), we show that the effect of CEACAM1 on EGF-dependent cell proliferation is mediated by its ability to bind to and sequester Shc, thus uncoupling EGFR signaling from the ras/MAPK pathway. In L-SACCI mice, we also show that impaired CEACAM1 phosphorylation leads to ligand-independent increase of EGFR-mediated cell proliferation. This appears to be secondary to visceral obesity and the metabolic syndrome, with increased levels of output of free fatty acids and heparin-binding EGF-fike growth factor from the adipose tissue of the mice. Thus, L-SACC1 mice provide a model for the mechanistic link between increased cell proliferation in states of impaired metabolism and visceral obesity.
引用
收藏
页码:944 / 952
页数:9
相关论文
共 59 条